CoChat

Desferrioxamine suppresses experimental allergic encephalomyelitis induced by MBP in SJL mice

Pedchenko, Tatyana V, LeVine, Steven M · 1998 · Journal of Neuroimmunology

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Abstract

Data from several studies indicate that free radicals have a pathogenic role in experimental allergic encephalomyelitis (EAE). Iron can contribute to free radical damage by catalyzing the formation of hydroxyl radical, inducing secondary initiation of lipid peroxidation and by promoting the oxidation of proteins. The iron chelator, desferrioxamine, can limit these oxidative reactions and it can scavenge peroxynitrite independent of iron chelation. Two previous studies have examined the therapeutic value of desferrioxamine in EAE. One study observed an effect when disease was induced by spinal cord homogenates (J. Exp. Med. 160, p. 1532, 1984), but a second study found no therapeutic value of desferrioxamine for myelin basic protein (MBP)-induced EAE (J. Neuroimmunol. 17, p. 127, 1988). In the second study, the drug was only administered during the preclinical stages of disease. Since desferrioxamine scavenges free radicals and prevents their formation, we hypothesized that the drug should be given during the active stage of disease to have therapeutic value. We first demonstrated that the drug enters the CNS around inflammatory cells in EAE animals. In animals treated during the active stage of MBP-induced EAE, the clinical signs were significantly reduced compared to vehicle-treated animals. The iron-bound form of this drug, ferrioxamine, was without therapeutic value. A derivative of desferrioxamine, hydroxylethyl starch (HES)-desferrioxamine, has a greater plasma half-life than desferrioxamine and it was also tested. Although there was a suggestion of improvement in these animals, the effects were less than that observed for desferrioxamine which may be related to the greater molecular size of HES-desferrioxamine. In summary, these data suggest that chelation of iron is an effective therapeutic target for EAE.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0165-5728(97)00256-7

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 44 references

Research works printed but not linked: 1

  1. Tangoren, 1991, Reducing brain edema in experimental concussive brain injury with post-injury treatment by polysaccharide–desferrioxamine, Soc. Neurosci. Abstr., 17, 163

Cited by

See all 78

Metadata

Authors
Pedchenko, T. V., & LeVine, S. M.
Affiliations
University of Kansas Medical Center (US)
Venue
Journal of Neuroimmunology
Publisher
Elsevier BV
Published
1998-04
Volume
84
Issue
2
Pages
188-197
ISSN
0165-5728 (ISSN-L)
OpenAlex
W2030389778
Cited by
78
References
44
Citations by year
2026: 1 · 2025: 1 · 2024: 4 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 3 · 2017: 1 · 2015: 1 · 2014: 5 · 2012: 7
FWCI
1.97
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Journal of Neuroimmunology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01ns033596-03)
  • National Institute of Neurological Disorders and Stroke (NS 33596)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD-02528)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
  • Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
  • Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
Keywords
deferoxamine, experimental autoimmune encephalomyelitis, myelin basic protein, iron chelation, free radicals, hydroxyl radicals, lipid peroxidation, peroxynitrite scavenging, ferrioxamine, SJL mice, multiple sclerosis treatment
MeSH terms
Animals, Deferoxamine, Demyelinating Diseases, Myelin Basic Protein, Encephalomyelitis, Autoimmune, Experimental, Ferric Compounds, Free Radicals, Hydroxyethyl Starch Derivatives, Immunohistochemistry, Iron, Iron Chelating Agents, Male, Mice, Inbred Strains, Myelin Sheath, Tissue Distribution, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Desferrioxamine suppresses experimental allergic encephalomyelitis induced by MBP in SJL mice. https://app.cochat.ai/papers/10.1016/s0165-5728(97)00256-7
The paper
Pedchenko, T. V., & LeVine, S. M. (1998). Desferrioxamine suppresses experimental allergic encephalomyelitis induced by MBP in SJL mice. Journal of Neuroimmunology. https://doi.org/10.1016/s0165-5728(97)00256-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.